Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||EL9262 / 2||- / -|
Administered by: Unknown Purchased by: ??
Symptoms: Angiogram pulmonary abnormal, Cough, Dizziness, Dyspnoea, Dyspnoea exertional, Gait disturbance, Pulmonary embolism, Deep vein thrombosis, Anticoagulant therapy, Computerised tomogram thorax abnormal, Walking distance test normal
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 5
Write-up: Patient is 75 years old male with no significant past medical history except from varicose vein. Patient also reported that he received 2nd dose of by the COVID-19 vaccine in February 2021 presented to ED with chief complaint of exertional shortness of breath and dizziness and cough for 10 days. Patient denies any long travel or prolonged immobilization. No known history of cancer. No recent surgery. Patient stated that he walked 5 mi every day and recently still able to walk but a little winded and need to work slowly due to shortness of breath. CTA chest showed Small caliber pulmonary embolus in the right lower lobe subsegmental pulmonary artery. No evidence of right heart strain. He also had bilateral below knee deep venous thrombosis involving the right posterior tibial vein and left peroneal vein. Patient was started on Eliquis and tolerated Eliquis. He had continuous persistent cough, and he was not found to have pneumonia. His cough improved with antitussives. He saturated well on walk test and was cleared for discharge home to follow up with Heme/onc for the remainder of the work up for hypercoagulable state.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166